Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.

Kessarin ThanapiromSirinporn SuksawatamnuayWattana SukeepaisarnjaroenPisit TangkijvanichSombat TreeprasertsukPanarat ThaimaiRujipat WasitthankasemYong PoovorawanPiyawat Komolmit

Published in: BMC gastroenterology (2017)

The DHCR7 polymorphism may be a pre-treatment predictive marker for response to PEG-IFN-based therapy in chronic HCV genotype 1 infection.

Keyphrases

end stage renal disease
dendritic cells
newly diagnosed
ejection fraction
chronic kidney disease
hepatitis c virus
prognostic factors
immune response
human immunodeficiency virus
combination therapy
cell therapy
drug induced